Vericel Corporation (NASDAQ:VCEL) Shorts Increased By 15.54% As Of Jun 27, 2018

June 27, 2018 - By Noel Courtney

Vericel Corporation (NASDAQ:VCEL) Corporate Logo

Change of 15.54% for Vericel Corporation (NASDAQ:VCEL)’s shares shorted was recorded. FINRA announced in June VCEL’s total 1.51 million shares shorted. The up change of 15.54% from 1.30M shares was reported. Previous VCEL’s position will need 2 days to restore. It has 738,700 average volume. Vericel Corporation float short is 5.3%.

Ticker’s shares touched $10.025 during the last trading session after 3.14% change.Vericel Corporation has volume of 416,568 shares. Since June 27, 2017 VCEL has risen 389.29% and is uptrending. VCEL outperformed the S&P500 by 376.72%.

Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, makes, markets, and sells patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions.The firm is worth $425.37 million. It markets three autologous cell therapy products, including Carticel and MACI, which are used for the treatment of cartilage defects in the knee; and Epicel, a permanent skin replacement that is used for the treatment of patients with deep-dermal or full-thickness burns comprising greater than or equal to 30 percent of total body surface area in the United States.Currently it has negative earnings. The firm also develops ixmyelocel-T, which is in Phase IIb clinical trial, a patient-specific multicellular therapy for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy.

Vericel Corporation (NASDAQ:VCEL) Ratings Coverage

Total analysts of 4 have positions in Vericel Corp (NASDAQ:VCEL) as follows: 4 rated it a “Buy”, 0 with “Sell” and 0 with “Hold”. The positive are 100%. Since January 2, 2018 according to StockzIntelligence Inc Vericel Corp has 7 analyst reports. The company rating was maintained by Piper Jaffray on Tuesday, January 2. On Monday, March 5 the stock of Vericel Corporation (NASDAQ:VCEL) has “Buy” rating given by BTIG Research. On Wednesday, March 28 the stock of Vericel Corporation (NASDAQ:VCEL) has “Buy” rating given by BTIG Research. On Thursday, April 12 BTIG Research maintained the shares of VCEL in report with “Buy” rating. On Wednesday, April 4 the rating was initiated by Leerink Swann with “Buy”. The stock rating was maintained by Leerink Swann with “Buy” on Wednesday, June 20.

Another two news for Vericel Corporation (NASDAQ:VCEL) were recently published by: on May 30, 2018 with title “Vericel Corporation Announces Proposed Public Offering of Common Stock”. The other‘s article was titled “Vericel Added to Russell 3000® Index” and published on June 25, 2018.

Vericel Corporation (NASDAQ:VCEL) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: